9-methoxy-8-(2-methoxyethoxy)-N2-(2-methoxyethyl)benzo[c][2,7]naphthyridine-2,4-diamine | 1055961-91-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 9-methoxy-8-(2-methoxyethoxy)-N2-(2-methoxyethyl)benzo[c][2,7]naphthyridine-2,4-diamine
• 英文别名: Benzo[c][2,7]naphthyridine, 6；9-methoxy-8-(2-methoxyethoxy)-2-N-(2-methoxyethyl)benzo[f][2,7]naphthyridine-2,4-diamine
• CAS: 1055961-91-5
• 化学式: C₁₉H₂₄N₄O₄
• 分子量: 372.424
• InChiKey: AZABWVYKNQPYTM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  27
• 可旋转键数：
  9
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  101
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  4-(cyanomethyl)-6-methoxy-7-(2-methoxyethoxy)quinoline-3-carbonitrile 、 2-甲氧基乙胺 以 四氢呋喃 为溶剂， 生成 9-methoxy-8-(2-methoxyethoxy)-N2-(2-methoxyethyl)benzo[c][2,7]naphthyridine-2,4-diamine
  参考文献：
  名称：

  Benzo[c][2,7]naphthyridines as inhibitors of PDK-1

  摘要：

  A series of substituted benzo[c][2,7]-naphthyridines were prepared and showed good potency in inhibiting PDK-1. The synthesis and SAR of this series of compounds are presented as well as the X-ray crystal structure of one of these analogs in a complex with PDK-1. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.07.007

文献信息

• Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof
  申请人：WISSNER Allan

  公开号：US20080293712A1

  公开（公告）日：2008-11-27

  The present invention relates to Benzo[c][2,7]naphthyridine Derivatives, compositions comprising an effective amount of a Benzo[c][2,7]naphthyridine Derivative, methods for treating or preventing a proliferative disorder or an autoimmune disease, comprising administering to a subject in need thereof an effective amount of a Benzo[c][2,7]naphthyridine Derivative, methods for modulating PDK-1 activity, PKA activity, Akt activity, S6K activity, or PKC activity, comprising administering to a subject in need thereof an effective amount of a Benzo[c][2,7]naphthyridine Derivative. The invention also relates to processes for preparing a Benzo[c][2,7]naphthyridine Derivative.

  本发明涉及苯并[c][2,7]萘啉衍生物，包含有效量苯并[c][2,7]萘啉衍生物的组合物，用于治疗或预防增殖性疾病或自身免疫疾病的方法，包括向需要治疗的受体内给予有效量的苯并[c][2,7]萘啉衍生物，用于调节PDK-1活性、PKA活性、Akt活性、S6K活性或PKC活性的方法，包括向需要治疗的受体内给予有效量的苯并[c][2,7]萘啉衍生物。本发明还涉及制备苯并[c][2,7]萘啉衍生物的过程。
• [EN] BENZO[C][2,7]NAPHTHYRIDINE DERIVATIVES, AND THEIR USE AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE BENZO[C][2,7]NAPHTYRIDINE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE KINASE
  申请人：WYETH CORP

  公开号：WO2008109613A1

  公开（公告）日：2008-09-12

  [EN] The present invention relates to Benzo[c] [2,7] naph thy ri dine Derivatives of formula (I), compositions comprising an effective amount of a Benzo[c] [2,7]naphthyridine Derivative, methods for treating or preventing a proliferative disorder or an autoimmune disease, comprising administering to a subject in need thereof an effective amount of a Benzo[c] [2,7]naphthyridine Derivative, methods for modulating PDK-I activity, PKA activity, Akt activity, S6K activity, or PKC activity, comprising administering to a subject in need thereof an effective amount of a Benzo[c] [2,7] naphthyridine Derivative. The invention also relates to processes for preparing a Benzo[c] [2,7] naphthyridine Derivative.
  [FR] L'invention concerne des dérivés de benzo[c][2,7]naphtyridine représentés par la formule (I), des compositions comprenant une quantité efficace de benzo[c][2,7]naphtyridine, des procédés pour le traitement ou la prévention d'un trouble prolifératif ou d'une maladie auto-immune, comprenant l'administration à un besoin de celui-ci d'une quantité efficace d'un dérivé de benzo[c][2,7]naphtyridine, des procédés pour la modulation de l'activité de PDK-I, l'activité de PKA, l'activité de AKT, l'activité de S6K ou l'activité de PKC, comprenant l'administration à un sujet en besoin de celui-ci d'une quantité efficace d'un dérivé de benzo[c][2,7]naphtyridine. L'invention concerne également des procédés pour la préparation d'un dérivé de benzo[c][2,7]naphtyridine représentés par la formule (I).
• Benzo[c][2,7]naphthyridines as inhibitors of PDK-1
  作者：Kyung-Hee Kim、Allan Wissner、Middleton B. Floyd、Heidi L. Fraser、Yanong D. Wang、Russell G. Dushin、Yongbo Hu、Andrea Olland、Bing Guo、Kim Arndt

  DOI：10.1016/j.bmcl.2009.07.007

  日期：2009.9

  A series of substituted benzo[c][2,7]-naphthyridines were prepared and showed good potency in inhibiting PDK-1. The synthesis and SAR of this series of compounds are presented as well as the X-ray crystal structure of one of these analogs in a complex with PDK-1. (C) 2009 Elsevier Ltd. All rights reserved.